{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:58:15Z","timestamp":1776329895412,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ped Infect Dis"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1093\/jpids\/piu034","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T00:26:07Z","timestamp":1399595167000},"page":"205-213","source":"Crossref","is-referenced-by-count":17,"title":["Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2\u201318 Years, Vaccine Adverse Event Reporting System, United States, July 2005\u2013June 2012"],"prefix":"10.1093","volume":"4","author":[{"given":"Penina","family":"Haber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro L.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Vellozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily Jane","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Broder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,5,7]]},"reference":[{"key":"2015082108524744000_4.3.205.1","unstructured":"MedImmune. FluMist [package insert]. Gaithersburg, MD: MedImmune; 2012 ."},{"key":"2015082108524744000_4.3.205.2","unstructured":"Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2004. MMWR 2004; 53:3\u20134."},{"key":"2015082108524744000_4.3.205.3","unstructured":"Harper SA Fukuda K Uyeki TM Using live attenuated influenza vaccine for prevention and control of influenza. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2003; 52:1\u20138."},{"key":"2015082108524744000_4.3.205.4","unstructured":"Food and Drug Administration. FDA approves nasal influenza vaccine for use in younger children. Rockville, MD: Food and Drug Administration; 2007. Available at http:\/\/www.fda.gov\/bbs\/topics\/news\/2007\/new01705.html. Accessed 12 February 2013."},{"key":"2015082108524744000_4.3.205.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.06.083"},{"key":"2015082108524744000_4.3.205.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1405"},{"key":"2015082108524744000_4.3.205.7","unstructured":"Centers for Disease Control and Prevention. Notice to readers: expansion of use of live attenuated influenza vaccine (FluMist) to children aged 2\u20134 years and other FluMist changes for 2007\u201308 influenza season. MMWR 2007; 56:1217\u20139."},{"key":"2015082108524744000_4.3.205.8","unstructured":"Fiore AE Uyeki TM Broder K Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 . MMWR Recomm Rep 2010; 59:1\u201362."},{"key":"2015082108524744000_4.3.205.9","unstructured":"Food and Drug Administration. FluMist Quadrivalent (Influenza Vaccine Live, Intranasal). http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM294307.pdf. Accessed 2 July 2012."},{"key":"2015082108524744000_4.3.205.10","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.108"},{"key":"2015082108524744000_4.3.205.11","unstructured":"Prevention of control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) \u2013 United States, 2012\u201313 influenza seasons. MMWR 2012; 61:613\u201318."},{"key":"2015082108524744000_4.3.205.12","unstructured":"Grohskopf LA Shay DK Shimabukuro TT Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), United States. MMWR 2013; 62 (RR07):1\u20134."},{"key":"2015082108524744000_4.3.205.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805143382002"},{"key":"2015082108524744000_4.3.205.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.21.2720"},{"key":"2015082108524744000_4.3.205.15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.6.e97"},{"key":"2015082108524744000_4.3.205.16","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200404000-00002"},{"key":"2015082108524744000_4.3.205.17","unstructured":"Zhou W Pool V Iskander JK Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) United States, 1991\u20132001. MMWR Surveill Summ 2003; 52:1\u201324."},{"key":"2015082108524744000_4.3.205.18","unstructured":"Medical Dictionary for Regulatory Activities. Available at: http:\/\/www.meddramsso.com. Accessed 13 February 2013."},{"key":"2015082108524744000_4.3.205.19","unstructured":"Food and Drug Administration. 21 CFR Part 600.80. Postmarketing reporting of adverse experiences. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=600.80. Accessed 12 February 2013."},{"key":"2015082108524744000_4.3.205.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.021"},{"key":"2015082108524744000_4.3.205.21","unstructured":"IOM (Institute of Medicine). Adverse Effects of Vaccines: Evidence and Causality. Washington DC: The National Academies Press; 2011."},{"key":"2015082108524744000_4.3.205.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.003"},{"key":"2015082108524744000_4.3.205.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.064"},{"key":"2015082108524744000_4.3.205.24","doi-asserted-by":"crossref","unstructured":"DuMouchel W Pregibon D . Empirical Bayes screening for multi-item associations. In: Proceeding of the Conference on Knowledge Discovery and Data; August 26\u201329, 2001; San Diego, CA: ACM Press:67\u201376.","DOI":"10.1145\/502512.502526"},{"key":"2015082108524744000_4.3.205.25","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225060-00001"},{"key":"2015082108524744000_4.3.205.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.113"},{"key":"2015082108524744000_4.3.205.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.02.039"},{"key":"2015082108524744000_4.3.205.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.055"},{"key":"2015082108524744000_4.3.205.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.08.050"},{"key":"2015082108524744000_4.3.205.30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit222"},{"key":"2015082108524744000_4.3.205.31","doi-asserted-by":"crossref","unstructured":"Kawai AT Li L Kulldorff M Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barr\u00e9 syndrome, encephalitis, or anaphylaxis in the 2012\u20132013 season. Pharmacoepidemiol Drug Saf 2014; Feb 4. doi:10.1002\/pds.3575 .","DOI":"10.1002\/pds.3575"},{"key":"2015082108524744000_4.3.205.32","doi-asserted-by":"publisher","DOI":"10.1159\/000324710"},{"key":"2015082108524744000_4.3.205.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.072"},{"key":"2015082108524744000_4.3.205.34","doi-asserted-by":"publisher","DOI":"10.1177\/1753465808093933"},{"key":"2015082108524744000_4.3.205.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.04.003"},{"key":"2015082108524744000_4.3.205.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065368"},{"key":"2015082108524744000_4.3.205.37","unstructured":"IOM (Institute of Medicine) 2007. Preventing Medication Errors: Quality Chasm Series. Committee on Identifying and Preventing Medication Errors. National Academy of Sciences Press."}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/4\/3\/205\/7953979\/piu034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T09:18:21Z","timestamp":1565428701000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article-lookup\/doi\/10.1093\/jpids\/piu034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,7]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,8,21]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1093\/jpids\/piu034"],"URL":"https:\/\/doi.org\/10.1093\/jpids\/piu034","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,7]]}}}